From the Lilly Research Laboratories, Eli Lilly and Company, Lilly
Corporate Center, Indianapolis, Ind.
Correspondence to James A. Clemens, PhD, Lilly Research Laboratories (0510), Eli Lilly and Co, Lilly Corporate Center, Indianapolis, IN 46285-0814.
Background and PurposeNuclear
factor-
MethodsRats were subjected to 30 minutes of forebrain
ischemia by 4-vessel occlusion (4-VO) and killed at 24 and 72
hours after ischemia. LY231617 was administered orally at a
dose of 50 mg/kg 30 minutes before 4-VO and again 4 hours after 4-VO.
Neuronal damage was evaluated in sections stained with cresyl violet.
Other sections were immunostained with antibodies to
NF-
ResultsThe administration of LY231617 had a significant
protective effect on hippocampal CA1 neurons at 72 hours after
ischemia (control group, 16±7 neurons/mm; treated group,
294±35 neurons/mm, P<.02) and prevented nuclear
translocation of activated NF-
ConclusionsActivation of NF-
Guest Editors,
Department of Neurological Surgery,
University of Miami School of Medicine,
Miami, Florida
© 1998 American Heart Association, Inc.
Original Contributions
Drug-Induced Neuroprotection From Global Ischemia Is Associated With Prevention of Persistent but Not Transient Activation of Nuclear Factor-
B in Rats
B (NF-
B) is an oxidative stress responsive transcription
factor that is transiently activated in most forebrain neurons
in response to transient global ischemia. However, in
hippocampal CA1 neurons destined to die, NF-
B remains persistently
activated. The present study was performed to determine
whether an antioxidant (LY231617) that afforded neuroprotection in
previous studies had any effect on NF-
B activation in hippocampal
CA1 neurons after global ischemia.
B p50 to assess nuclear localization. An electrophoretic mobility
shift assay was performed on nuclear extracts from sham- and
LY231617-treated rats at 24 and 72 hours after ischemia.
B as normally seen at 72 hours
after ischemia in untreated controls. In contrast, the
untreated controls showed activated NF-
B at 72 hours after
ischemia. At 24 hours after ischemia, both the control
group and the LY231617 group showed intense nuclear localization of
NF-
B.
B in vitro has been reported to
promote proapoptotic as well as antiapoptotic
mechanisms, depending on the cell type being investigated. In the
present in vivo study, the role of the transient activation of
NF-
B observed at 24 hours may be responsible for the induction of
protective factors in neurons that survive the ischemic insult,
whereas the persistent activation of NF-
B in hippocampal neurons
could be responsible for the induction of proteins that result in CA1
neuronal death.
Editorial Comment
This article has been cited by other articles:
![]() |
J. Bohuslav, L.-f. Chen, H. Kwon, Y. Mu, and W. C. Greene p53 Induces NF-{kappa}B Activation by an I{kappa}B Kinase-independent Mechanism Involving Phosphorylation of p65 by Ribosomal S6 Kinase 1 J. Biol. Chem., June 18, 2004; 279(25): 26115 - 26125. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Williams, R. Berti, J. R. Dave, P. J. Elliot, J. Adams, and F. C. Tortella Delayed Treatment of Ischemia/Reperfusion Brain Injury: Extended Therapeutic Window with the Proteosome Inhibitor MLN519 Stroke, May 1, 2004; 35(5): 1186 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. TEGEDER, J. PFEILSCHIFTER, and G. GEISSLINGER Cyclooxygenase-independent actions of cyclooxygenase inhibitors FASEB J, October 1, 2001; 15(12): 2057 - 2072. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bachis, A. M. Colangelo, S. Vicini, P. P. Doe, M. A. De Bernardi, G. Brooker, and I. Mocchetti Interleukin-10 Prevents Glutamate-Mediated Cerebellar Granule Cell Death by Blocking Caspase-3-Like Activity J. Neurosci., May 1, 2001; 21(9): 3104 - 3112. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Phillips, A. J. Williams, J. Adams, P. J. Elliott, F. C. Tortella, and J. A. Clemens Proteasome Inhibitor PS519 Reduces Infarction and Attenuates Leukocyte Infiltration in a Rat Model of Focal Cerebral Ischemia Editorial Comment Stroke, July 1, 2000; 31(7): 1686 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Hickenbottom, J. C. Grotta, R. Strong, L. A. Denner, J. Aronowski, and R. L. Macdonald Nuclear Factor-{kappa}B and Cell Death After Experimental Intracerebral Hemorrhage in Rats • Editorial Comment Stroke, November 1, 1999; 30 (11): 2472 - 2478. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yu, D. Zhou, A. J. Bruce-Keller, M. S. Kindy, and M. P. Mattson Lack of the p50 Subunit of Nuclear Factor-kappa B Increases the Vulnerability of Hippocampal Neurons to Excitotoxic Injury J. Neurosci., October 15, 1999; 19(20): 8856 - 8865. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, J. A. Clemens, T. Yin, D. T. Stephenson, E. M. Johnstone, Y. Du, J. A. Panetta, S. M. Paul, and S. P. Little Rat B2 Sequences Are Induced in the Hippocampal CA1 Region After Transient Global Cerebral Ischemia J. Biol. Chem., October 1, 1999; 274(40): 28674 - 28681. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lipton Ischemic Cell Death in Brain Neurons Physiol Rev, October 1, 1999; 79(4): 1431 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Luo, A. Hattori, J. Munoz, Z.-H. Qin, and G. S. Roth Intrastriatal Dopamine Injection Induces Apoptosis Through Oxidation-Involved Activation of Transcription Factors AP-1 and NF-kappa B in Rats Mol. Pharmacol., August 1, 1999; 56(2): 254 - 264. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |